TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Ytterby Life Science AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,394
|
1,190 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
347
|
324 | |
| EBITDA |
234
|
230 | |
| Total assets |
619
|
514 | |
| Current assets |
589
|
485 | |
| Current liabilities |
59
|
50 | |
| Equity capital |
502
|
424 | |
| - share capital |
51
|
47 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.1%
|
82.5% | |
| Turnover per employee |
1,394
|
1,190 | |
| Profit as a percentage of turnover |
24.9%
|
27.2% | |
| Return on assets (ROA) |
56.1%
|
63.0% | |
| Current ratio |
998.3%
|
970.0% | |
| Return on equity (ROE) |
69.1%
|
76.4% | |
| Change turnover |
120
|
177 | |
| Change turnover % |
-21%
|
9%
|
17% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.